Serenis-preview

Serenis

Private

MilanHealthcare & Life Scienceshttps://serenis.it

Last Round

Series A

Sep 29, 2025

Total Funding Raised

$20.87M

Momentum Score

25 /100

Company Overview

Serenis is a digital health company that provides an online platform for mental health services, including psychotherapy, psychiatry, nutrition, and coaching.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, HR, Telemedicine

Business Model

B2C

Customer Profile

Usage-Based SaaS, Subscription SaaS, Marketplace Commission

AI Layer

Non-AI

Keywords

online therapymental health platformteletherapyonline psychotherapycorporate wellnessemployee mental healthemployee assistance programonline psychiatrytherapist matchingcouples therapytelehealthlicensed medical centerpay-per-sessiononline nutrition counselingtherapist network

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Serenis Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Serenis Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Sep 29, 2025
Seed	Nov 10, 2022
Pre Seed	Feb 8, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

Silvia Wang

Co-Founder CEO

Founding Team

Serena Rossetti

CFO

Executive Team

Ettore Penazzato

COO

Executive Team

Carlo Alberto Gaetaniello

Chief Product Officer, Director Of Business Development

Executive Team

View all key people

Serenis Investors

Notable investors and investment history

Investor	Rounds
Azimut Libera Impresa SGR	Series A
FG2 Capital	Series A, Seed
Club degli Investitori	Series A
Lumen Ventures	Seed, Series A
Angelini Ventures	Seed, Series A
CDP Venture Capital SGR	Series A
Doorway Spa Società Benefit	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Dec 22, 2025
Added Unifarco S.p.A. from the Pharmaceuticals/Cosmetics industry.
Oct 1, 2025
Launched Serenis Studio for in-person therapy sessions.

View all signals

Serenis Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Serenis Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Serenis's valuation, stock price, and market status.

Firmographic Details

HeadquartersMilan

Employee Range672

Year Founded2021

Last FundingSep 29, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.